BioLineRx Ltd.
BLRX
$2.75
-$0.32-10.42%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.72% | -13.58% | -29.71% | -6.40% | -54.50% |
| Total Receivables | -88.20% | -82.35% | -92.67% | -42.47% | 445.62% |
| Inventory | -31.70% | -38.46% | -21.57% | 14.75% | 61.03% |
| Prepaid Expenses | -54.63% | -63.11% | -63.82% | -75.81% | -57.73% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -81.04% |
| Total Current Assets | -12.63% | -24.64% | -35.12% | -10.57% | -42.56% |
|
|
|||||
| Total Current Assets | -12.63% | -24.64% | -35.12% | -10.57% | -42.56% |
| Net Property, Plant & Equipment | -36.73% | -45.84% | -44.49% | -32.40% | -28.34% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 56.65% | -21.58% | -23.97% | -26.49% | -29.66% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 5.14% | -24.53% | -33.02% | -15.68% | -39.14% |
|
|
|||||
| Total Accounts Payable | -37.44% | -23.66% | -44.70% | -43.16% | -48.63% |
| Total Accrued Expenses | -61.51% | -- | -- | -- | -4.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -5.76% | -53.81% | -56.19% | 23.56% | 36.16% |
| Total Finance Division Other Current Liabilities | 60.38% | -67.68% | -66.70% | -78.56% | -93.23% |
| Total Other Current Liabilities | 60.38% | -67.68% | -66.70% | -78.56% | -93.23% |
| Total Current Liabilities | -21.31% | -45.24% | -49.28% | -41.26% | -63.99% |
|
|
|||||
| Total Current Liabilities | -21.31% | -45.24% | -49.28% | -41.26% | -63.99% |
| Long-Term Debt | -50.21% | -68.86% | -64.25% | 28.54% | 35.15% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.62% | -22.43% | -23.76% | -19.85% | -16.20% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -30.99% | -54.18% | -54.17% | -41.24% | -49.81% |
|
|
|||||
| Common Stock & APIC | 2.35% | 3.42% | 3.22% | 2.42% | 1.28% |
| Retained Earnings | -0.29% | -0.75% | -2.00% | -0.87% | -2.36% |
| Treasury Stock & Other | -15.41% | 4.26% | 8.12% | 10.50% | 26.52% |
| Total Common Equity | 35.18% | 129.66% | 43.57% | 59.74% | 1.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 35.18% | 129.66% | 43.57% | 59.74% | 1.80% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 73.43% | 129.66% | 43.57% | 59.74% | 1.80% |
|
|
|||||